Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	90
Update on management of cerebral venous thrombosis	85
Management of neuropsychiatric symptoms in dementia	53
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	52
Assessing treatment response in multiple sclerosis	52
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment	49
Editorial introductions	49
Historical development and contemporary use of neuromodulation in human spinal cord injury	45
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population	42
Neurosyphilis in 2025: Erratum	41
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	39
Central nervous system adverse events of immune checkpoint inhibitors	37
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond	35
Gene therapies for CMT neuropathies: from the bench to the clinic	30
Hereditary motor neuropathies	30
The role of the gut microbiome in Alzheimer's disease pathophysiology	30
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	29
Neurology education in the era of artificial intelligence	29
Editorial introductions	28
Multiple sclerosis in China: the current state of diagnosis and management	27
Updates in neuro-otology	27
Editorial: Epilepsy advances in 2023	27
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	26
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	25
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention	25

Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	24
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	24
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	24
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	24
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	24
Threat of resurgence or hope for global eradication of poliovirus?	24
Clinical impact of molecular profiling in rare brain tumors	23
Levodopa infusion therapies for Parkinson disease	23
The FSHD jigsaw: are we placing the tiles in the right position?	23
Global to individual: key domains of burden in pediatric headache	22
Thymectomy in myasthenia gravis	22
Nerve ultrasound in the diagnosis of inflammatory neuropathies	22
Migraine in women: a review	22
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	22
Red flags in multiple sclerosis	22
Diet and migraine: what is proven?	21
Update on dermatomyositis	21
fMRI-based spatio-temporal parcellations of the human brain	21
Idiopathic intracranial hypertension: expanding our understanding	20
Gauging and controlling excitability in cortical disorders	20
MRI for the diagnosis of limb girdle muscular dystrophies	20
Acute stroke care in low and middle-income countries	19
Parkinson's disease – genetic cause	19
Novel pharmacological therapies in development	19
Electrical stimulation of the peripheral and central vestibular system	19
MRI in multiple sclerosis: progress in in-vivo pathobiology	19
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum	18
Targeting IDH1/IDH2 mutations in gliomas	18
Obesity-related neuropathy: the new epidemic	18
Editorial: The gap between academic advances and therapy development in motor neuron disease	18
Novel approaches to treatment of leptomeningeal metastases	17
Editorial introductions	17
Progress in spinal muscular atrophy research	17
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	17
New developments in diagnostics and treatment of adult-onset focal dystonia	17
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	17
Neuroinflammation and immunometabolism in neurodegenerative diseases	16
Optic neuritis: current challenges in diagnosis and management	16
Neurosyphilis in 2025	16
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	16
Recent advances in Alzheimer disease genetics	16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	16
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	15
New insights in the immune treatment of Guillain–Barré syndrome	15
Update on genetics of amyotrophic lateral sclerosis	15
The state of art on the use of patient reported outcomes in migraine	15
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	15
Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis	15
Recent insights in striated muscle laminopathies	15
Monitoring multiple sclerosis: digital and fluid phase biomarkers	15

Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	15
Abnormal energy metabolism in ALS: a key player?	14
Sex and gender differences in neurological infections	14
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	14
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology	14
PET imaging of microglial pathology in multiple sclerosis	14
Imaging cortical lesions in multiple sclerosis	14
Current trend in air pollution exposure and stroke	14
Update on modifiable risk factors for Alzheimer's disease and related dementias	14
Diagnosing viral encephalitis and emerging concepts	14
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	13
Converging perspectives in vestibular neurology	13
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	13
Precision medicine in Moyamoya vasculopathy	13
Imaging of vestibular function and disorders and its clinical relevance	13
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches	13
Editorial introductions	13
Long COVID and especially headache syndromes	12
Current gaps in acute reperfusion therapies	12
Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes	12
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	12
Muscle ultrasound in myopathies	12
Deep brain stimulation of the mesencephalic locomotor region or lateral hypothalamus for facilitation of walking after spinal cord injury	12
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	12
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease: Erratum	12
Editorial: Seizure disorders: 2023 update	12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	12
Peripheral visual field loss and activities of daily living	12
An update on psychogenic nonepileptic seizures	11
Progress in treatment of gliomas	11
Nonneurologic causes of binocular diplopia for the neurologist	11
Therapeutic thoroughfares for adults living with Pompe disease	11
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	11
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	11
Update on functional vestibular and gait disorders	11
Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches	11
Editorial: Cerebrovascular disease	11
Perception and control of a virtual body in immersive virtual reality for rehabilitation	10
Acute vertigo: stroke or not?	10
Editorial: Advances in brain tumors management: new perspectives and challenges	10
Editorial introductions	10
Editorial introductions	10
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	10
Editorial:Framing artificial intelligence to neuromuscular disorders	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Multiple sclerosis: advances and challenges in diagnosis	10
Emerging concepts and therapies for amyotrophic lateral sclerosis	10
Editorial introductions	10
Atypical forms of Alzheimer's disease: patients not to forget	9
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road	9
New targets in spontaneous intracerebral hemorrhage	9
AI in epilepsy neuroimaging	9
Barriers to clinical genetic testing in movement disorders	9
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	9
The current landscape of epilepsy genetics: where are we, and where are we going?	8
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	8
PET-based brain molecular connectivity in neurodegenerative disease	8
Editorial: Current opinions in neurology editorial	8
Editorial introductions	8
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	8
Headache in infections	8
Shifting our attention earlier in the multiple sclerosis disease course	8
Editorial improving movement disorders healthcare across the globe	8
Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies	8
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	7
Congenital myasthenic syndromes: increasingly complex	7
Investigational approaches to multiple sclerosis therapy	7
Recent insights into haematology and peripheral nerve disease	7
Editorial: Update on movement disorders	7
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	7
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	7
The role of caffeine in headache disorders	7
Autoimmune neuromyotonia	7
Editorial introductions	7
The genetics of multiple sclerosis: an updated perspective	7
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	7
Imaging and neuromodulation in Parkinson's disease	7
Recent advances in stroke biomarkers – implications for prognosis and treatment	7
The genetics of amyotrophic lateral sclerosis	7
Medical and neurologic management of brain tumor patients	6

An update on multiple system atrophy	6
Recent advances in epilepsy surgery	6
Editorial introductions	6
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	6
Current understanding of skeletal muscle repeat expansion disorders	6
Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update	6
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective	6
Autoimmune nodopathies, an emerging diagnostic category	6
Emerging neuroinfectious diseases: public health implications	6
Leprous neuropathy	6
Persistent aura without infarction	6
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	6
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	6
Recent advances in the genetics of Parkinson's disease in underrepresented populations	6
Novel pathophysiological insights in autoimmune myasthenia gravis	6
Genetics of ALS – genes and modifier	6
Brain health in HIV: pathogenesis, classification, and treatment	6
Current drug treatment of myasthenia gravis	6
Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area	5
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment	5
Immunology of multiple sclerosis: an update	5
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	5
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	5
The evolving spectrum of complex inherited neuropathies	5
Mechanisms of paraneoplastic neurological syndromes	5
Epilepsy advances in 2025	5
Novel trial designs in neuro-oncology	5
Late-onset myopathies	5
Recent advances, challenges and perspectives in cerebrovascular disease	5
Systemic vasculitis and headache	5
Defining the presymptomatic phase of frontotemporal dementia	5
Ambulatory seizure detection	5
Spasticity following brain and spinal cord injury: assessment and treatment	5
Advances in myopathy research: promising developments and challenges	5
The current clinical perception of myotonic dystrophy type 2	5
Somatic mosaicism in focal epilepsies	5
Vestibular syncope	5
Editorial introductions	5
Recent developments in multiple sclerosis neuropathology	5
Neuro-vestibular rehab: new developments	4
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Advances in functional and structural imaging of the brainstem: implications for disease	4
The cortical vestibular system: insights from electroencephalography	4
Epidemiology and genetics of Meniere's disease	4
Neuroscience and oncology: state-of-the-art and new perspectives	4
Noninvasive brain stimulation to improve motor outcomes after stroke	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
Noninvasive methods to monitor intracranial pressure	4
Reproducibility and replicability in neuroimaging data analysis	4
The impact of climate change on neuroinfectious diseases	4
Traumatic peripheral nerve injuries: diagnosis and management	4
Progress in the identification of unstable carotid artery plaque	4
Traumatic brachial plexus injury: diagnosis and treatment	4
Recent advances in our understanding of genetic rhabdomyolysis	4
Big data in multiple sclerosis	4
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data	4
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	4
Diagnostic criteria for amyotrophic lateral sclerosis	4
Re-defining progression in multiple sclerosis	4
Myoclonus: an update	4